Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: A 7.5-year longitudinal study in a routine cytology-based screening population in West Germany

Journal of Medical Virology

Volumn 80, Issue 10, 2008, Pages 1814-1823

  Kovács, Krisztina ^a   Varnai, Alinda D ^b   Bollmann, Magdolna ^b   Bankfalvi, Agnes ^c   Szendy, Marianna ^b   Speich, Norbert ^d   Schmitt, Christoph ^d   Pajor, László ^a   Bollmann, Reinhard ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d IMoGen GmbH   (Germany)

Author keywords

Cervical cancer; HPV co infection; Prevalence; Screening

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CYTOLOGY; FEMALE; GENE SEQUENCE; GENOTYPE; GERMAN FEDERAL REPUBLIC; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; SCREENING TEST; UTERINE CERVIX; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN; VIRUS TYPING; WART VIRUS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GERMANY, WEST; HUMANS; LONGITUDINAL STUDIES; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 50849091985     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21282     Document Type: Article

References (27)

1. Bollmann R, Mehes G, Torka R, Speich N, Schmitt C, Bollmann M. 2003. Human papillomavirus typing and DNA ploidy determination of squamous intraepithelial lesions in liquid-based cytologic samples. Cancer Cytopathol 99:57-62.
2. Bollmann M, Bankfalvi A, Trosic A, Speich N, Schmitt C, Mollmann R. 2005. Can we detect cervical human papillomavirus (HPV) infection by cytomorphology alone? Diagnostic value of non-classic cytological signs of HPV effect in minimally abnormal Pap tests. Cytopathology 16:13-21.
3. Bollmann R, Bánkfalvi A, Griefingholt H, Trosic A, Speich N, Schmitt C, Bollmann M. 2005. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: Results from 31031 women from the Bonn-region in West Germany. Oncol Rep 13:915-922.
4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
5. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. 2002. The causal relation between human papillomaviruses and cervical cancer. J Clin Pathol 55:244-265.
6. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E. 2004. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57:68-72.
7. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruse. Virology 324:17-27.
8. Fife KH, Cramer HM, Schroeder JM, Brown DR. 2001. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64:550-559.
9. Gravitt EP, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS. 2007. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol 45:3245-3250.
10. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464-474.
11. Klug SJ, Hukelmann M, Hollwitz B, Düzenli N, Schopp B, Petry KU, Iftner T. 2007. Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol 79:616-625.
12. Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, Linhares I, Segurado A, Vanderborght B, Neto JE, Van Doorn LJ. 2002. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 40:3341-3345.
13. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. 2003. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
14. Nobbenhuis M, Walboomers JM, Heimerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet: 354:20-25.
15. Petry KU, Menton S, Menton M, van Loenen-Frosch F, de Carvalho GH, Holz B, Schopp B, Garbrecht-Buettner S, Davies P, Boehmer G, van den Akker E, Iftner T. 2003. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients. Br J Cancer 88:1570-1577.
16. Rozendaal L, Walboomers JM, van der Linden JC, Walboomers JM, Voorhorst FJ, Risse EK, Boon ME, Meijer CJ. 2000. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CINIII in women with normal cytology and borderline changes. J Clin Pathol 53:606-611.
17. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton C, Manos MM. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958-964.
18. Schneider A, Hoyer H, Lotz B, Leistritza S, Kühne-Heid R, Nindl I, Müller B, Haerting J, Dürst M. 2000. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 89:529-534.
19. Snijders PJF, van den Brule AJC, Meijer CJLM. 2003. The clinical relevance of human papillomavirus testing: Relationship between analytical and clinical sensitivity. J Pathol 201:1-6.
20. Soost HJ. 1990. Befundwiedergabe in der gynäkologischen Zytodiagnostik - Münchener Normenklatur II. Gynäkol Prax 14:433-438.
21. Speich N, Schmitt C, Bollmann R, Bollmann M. 2004. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: Genotype spectrum of patients from the West German area. J Med Microbiol 53:125-128.
22. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2006. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15:1274-1280.
23. van den Brule AJC, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJL, Snijders PJF. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779-787.
24. van der Graaf Y, Molijn A, Doornewaard H, van den Tweel J. 2002. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156:158-164.
25. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
26. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. 1999. Type-specific persistence of human papillomavirus DNA before the developments of invasive cervical cancer. N Engl J Med 341:1633-1638.
27. Woodman CG, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. 2001. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 357:1831-1836.